The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127818511 12781851 1 I 20110721 20160926 20160926 EXP US-ASTRAZENECA-2016SF02100 ASTRAZENECA 0.00 M Y 0.00000 20160927 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127818511 12781851 1 PS SYNAGIS PALIVIZUMAB 1 Intramuscular 98.0MG ONCE/SINGLE ADMINISTRATION 436 MG U UNKNOWN 0 98 MG INJECTION
127818511 12781851 2 SS SYNAGIS PALIVIZUMAB 1 Intramuscular 98.0MG ONCE/SINGLE ADMINISTRATION 436 MG U UNKNOWN 0 98 MG INJECTION
127818511 12781851 3 SS SYNAGIS PALIVIZUMAB 1 Intramuscular 105.0MG ONCE/SINGLE ADMINISTRATION 436 MG U UNKNOWN 0 105 MG INJECTION
127818511 12781851 4 SS SYNAGIS PALIVIZUMAB 1 Intramuscular 105.0MG ONCE/SINGLE ADMINISTRATION 436 MG U UNKNOWN 0 105 MG INJECTION
127818511 12781851 5 SS SYNAGIS PALIVIZUMAB 1 Intramuscular 113.0MG ONCE/SINGLE ADMINISTRATION 436 MG U UNKNOWN 0 113 MG INJECTION
127818511 12781851 6 SS SYNAGIS PALIVIZUMAB 1 Intramuscular 113.0MG ONCE/SINGLE ADMINISTRATION 436 MG U UNKNOWN 0 113 MG INJECTION
127818511 12781851 7 SS SYNAGIS PALIVIZUMAB 1 Intramuscular 120.0MG ONCE/SINGLE ADMINISTRATION 436 MG U UNKNOWN 0 120 MG INJECTION
127818511 12781851 8 SS SYNAGIS PALIVIZUMAB 1 Intramuscular 120.0MG ONCE/SINGLE ADMINISTRATION 436 MG U UNKNOWN 0 120 MG INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127818511 12781851 1 Premature baby
127818511 12781851 2 Antiviral prophylaxis
127818511 12781851 3 Premature baby
127818511 12781851 4 Antiviral prophylaxis
127818511 12781851 5 Premature baby
127818511 12781851 6 Antiviral prophylaxis
127818511 12781851 7 Premature baby
127818511 12781851 8 Antiviral prophylaxis

Outcome of event

Event ID CASEID OUTC COD
127818511 12781851 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127818511 12781851 Nosocomial infection
127818511 12781851 Respiratory syncytial virus test positive

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127818511 12781851 1 20101119 20101119 0
127818511 12781851 2 20101119 20101119 0
127818511 12781851 3 20101221 20101221 0
127818511 12781851 4 20101221 20101221 0
127818511 12781851 5 20110118 20110118 0
127818511 12781851 6 20110118 20110118 0
127818511 12781851 7 20110228 20110228 0
127818511 12781851 8 20110228 20110228 0